We have investigated the expression of bcl-2 protein in a panel of sma
ll cell lung carcinoma (SCLC) cells lines. Five of six cell lines exam
ined expressed relatively high levels of bcl-2 protein and transcripts
. The bcl-2 expression in SCLC cells, however, was not always associat
ed with myc expression. Since dysregulation of bcl-2 may be involved i
n the course of tumorigenesis and/or in the acquisition of drug resist
ance of tumor cells, the expression of bcl-2 in SCLC cells may become
an important indicator in the prognosis or treatment of SCLC.